Madrigal Pharmaceuticals (MDGL) PT Lowered to $131 at B.Riley
Tweet
Share
E-mailGet Alerts MDGL Hot Sheet
Price: $513.02 -1.12%
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
B.Riley analyst Mayank Mamtani lowered the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $131.00 (from $174.00) while maintaining a Buy rating.
You May Also Be Interested In
- Citi initiates Madrigal Pharmaceuticals coverage with Buy rating
- UiPath Inc. (PATH) PT Lowered to $15 at UBS Following Investor Day
- Northern Star Resources (NST:AU) (NESRF) PT Lowered to AUD19 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
